Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States

Breast Cancer Research and Treatment

Volumn 116, Issue 3, 2009, Pages 587-594

  Atkinson, Charlotte ^a   Newton, Katherine M ^b,c   Aiello Bowles, Erin J ^c   Lehman, Constance D ^d   Stanczyk, Frank Z ^e   Westerlind, Kim C ^f   Li, Lin ^a   Lampe, Johanna W ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d SEATTLE CANCER CARE ALLIANCE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

Equol; Isoflavones; Mammographic breast density; O Desmethylangolensin; Phytoestrogen metabolism; Premenopausal women

Indexed keywords

EQUOL; FLAVONOID; NORANGOLENSIN; UNCLASSIFIED DRUG; DAIDZEIN; ESTRONE DERIVATIVE; ISOFLAVONE DERIVATIVE; O DESMETHYLANGOLENSIN; O-DESMETHYLANGOLENSIN; PHYTOESTROGEN;

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HORMONE SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; SOYBEAN; UNITED STATES; BREAST; BREAST TUMOR; HISTOLOGY; MASS FRAGMENTOGRAPHY; METABOLISM; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; URINE;

ADULT; BREAST; BREAST NEOPLASMS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROXYESTRONES; ISOFLAVONES; MAMMOGRAPHY; MIDDLE AGED; PHENOTYPE; PHYTOESTROGENS; SOY FOODS;

EID: 70349576211     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0199-7     Document Type: Article

References (56)

1. Boyd NF, Rommens JM, Vogt K et al (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808. doi:10.1016/S1470-2045(05)70390-9
2. Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344:276-285. doi:10.1056/NEJM200101253440407
3. Kurzer MS (2002) Hormonal effects of soy in premenopausal women and men. J Nutr 132:570S-573S
4. Kurzer MS (2000) Hormonal effects of soy isoflavones: studies in premenopausal and postmenopausal women. J Nutr 130:660S-661S
5. Trock BJ, Hilakivi-Clarke L, Clarke R (2006) Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98:459-471
6. Maskarinec G, Takata Y, Franke AA et al (2004) A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr 134:3089-3094
7. Maskarinec G, Meng L (2001) An investigation of soy intake and mammographic characteristics in Hawaii. Breast Cancer Res 3:134-141. doi:10.1186/bcr285
8. Maskarinec G, Lyu LC, Meng L et al (2001) Determinants of mammographic densities among women of Asian, Native Hawaiian, and Caucasian ancestry. Ethn Dis 11:44-50
9. Nagel G, Mack U, von Fournier D et al (2005) Dietary phytoestrogen intake and mammographic density-results of a pilot study. Eur J Med Res 10:389-394
10. Ursin G, Sun CL, Koh WP et al (2006) Associations between soy, diet, reproductive factors, and mammographic density in Singapore chinese women. Nutr Cancer 56:128-135. doi:10.1207/s15327914nc5602-2
11. Maskarinec G, Williams AE, Carlin L (2003) Mammographic densities in a 1 year isoflavone intervention. Eur J Cancer Prev 12:165-169. doi:10.1097/ 00008469-200304000-00011
12. Atkinson C, Warren RM, Sala E et al (2004) Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial. Breast Cancer Res 6:R170-R179. ISRCTN42940165. doi:10.1186/bcr773
13. Rowland IR, Wiseman H, Sanders TA et al (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36:27-32. doi:10.1207/S15327914NC3601-5
14. Akaza H, Miyanaga N, Takashima N et al (2002) Is daidzein nonmetabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn J Clin Oncol 32:296-300. doi:10.1093/jjco/hyf064
15. Kelly GE, Joannou GE, Reeder AY et al (1995) The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med 208:40-43
16. Lampe JW, Karr SC, Hutchins AM et al (1998) Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 217:335-339
17. Hutchins AM, Slavin JL, Lampe JW (1995) Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc 95: 545-551. doi:10.1016/S0002- 8223(95)00149-2
18. Arai Y, Uehara M, Sato Y et al (2000) Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 10:127-135
19. Frankenfeld CL, McTiernan A, Tworoger SS et al (2004) Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes. J Steroid Biochem Mol Biol 88:399-408. doi:10.1016/j.jsbmb.2004.01.006
20. Atkinson C, Frankenfeld CL, Lampe JW (2005) Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 230:155-170
21. Evans BA, Griffiths K, Morton MS (1995) Inhibition of 5 alphareductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147:295-302
22. Pelissero C, Lenczowski MJ, Chinzi D et al (1996) Effects of flavonoids on aromatase activity, an in vitro study. J Steroid Biochem Mol Biol 57:215-223. doi:10.1016/0960-0760(95)00261-8
23. Adlercreutz H, Bannwart C, Wahala K et al (1993) Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44:147-153. doi:10.1016/0960-0760(93)90022-O
24. Setchell KD, Brown NM, Lydeking-Olsen E (2002) The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132:3577-3584
25. Adlercreutz H, Martin F, Pulkkinen M et al (1976) Intestinal metabolism of estrogens. J Clin Endocrinol Metab 43:497-505
26. Duncan AM, Merz-Demlow BE, Xu X et al (2000) Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9:581-586
27. Frankenfeld CL, McTiernan A, Aiello EJ et al (2004) Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Cancer Epidemiol Biomarkers Prev 13:1156-1162
28. Fuhrman BJ, Teter BE, Barba M et al (2008) Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:33-42. doi:10.1158/1055-9965.EPI-07- 0193
29. Atkinson C, Newton KM, Bowles EJ et al (2008) Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States. Am J Clin Nutr 87:679-687
30. Taplin SH, Ichikawa L, Buist DS et al (2004) Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev 13:225-234. doi:10.1158/1055-9965.EPI-03-0206
31. Liberman L, Menell JH (2002) Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am 40:409-430. doi: 10.1016/S0033-8389(01)00017-3
32. Atkinson C, Newton KM, Stanczyk FZ et al (2008) Daidzeinmetabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States. Cancer Causes Control (Epub ahead of print)
33. Boyd NF, Byng JW, Jong RA et al (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87:670-675. doi:10.1093/jnci/87.9.670
34. Yong M, Atkinson C, Newton KM et al (2008) Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women (In preparation)
35. Bonorden MJ, Greany KA, Wangen KE et al (2004) Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women. Eur J Clin Nutr 58:1635-1642. doi:10.1038/sj.ejcn.1602020
36. Wiseman H, Casey K, Bowey EA et al (2004) Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 80:692-699
37. Boyd NF, Stone J, Martin LJ et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87:876-882. doi:10.1038/sj.bjc.6600537
38. Boyd N, Martin L, Stone J et al (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048-1053
39. Cerhan JR, Sellers TA, Janney CA et al (2005) Prenatal and perinatal correlates of adult mammographic breast density. Cancer Epidemiol Biomarkers Prev 14:1502-1508. doi:10.1158/1055-9965.EPI-04-0762
40. Vachon CM, Kuni CC, Anderson K et al (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11:653-662. doi:10.1023/A:1008926607428
41. Noh JJ, Maskarinec G, Pagano I et al (2006) Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast 15:20-28. doi:10.1016/j.breast.2005.04.014
42. Titus-Ernstoff L, Tosteson AN, Kasales C et al (2006) Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 17:1281-1290. doi:10.1007/s10552-006-0071-1
43. Riza E, dos Santos Silva I, De Stavola B et al (2005) Correlates of high-density mammographic parenchymal patterns by menopausal status in a rural population in Northern Greece. Eur J Cancer 41:590-600. doi:10.1016/j.ejca.2004. 12.014
44. Riza E, dos Santos Silva I, De Stavola B et al (2001) Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women. Cancer Epidemiol Biomarkers Prev 10:627-634
45. Tamimi RM, Hankinson SE, Colditz GA et al (2005) Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 14:2641-2647. doi:10.1158/1055-9965.EPI-05-0558
46. Aiello EJ, Tworoger SS, Yasui Y et al (2005) Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 14:1411-1417. doi:10.1158/1055-9965.EPI-04-0920
47. Boyd NF, Lockwood GA, Byng JW et al (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133-1144
48. McKinlay SM, Brambilla DJ, Posner JG (1992) The normal menopause transition. Maturitas 14:103-115. doi:10.1016/0378-5122(92)90003-M
49. McKinlay SM (1996) The normal menopause transition: an overview. Maturitas 23:137-145. doi:10.1016/0378-5122(95)00985-X
50. Burger HG, Dudley EC, Hopper JL et al (1999) Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 84:4025-4030. doi:10.1210/jc.84.11.4025
51. Burger HG, Dudley EC, Robertson DM et al (2002) Hormonal changes in the menopause transition. Recent Prog Horm Res 57:257-275. doi:10.1210/rp.57.1.257
52. Frankenfeld CL, Atkinson C, Thomas WK et al (2005) High concordance of daidzein-metabolizing phenotypes in individuals measured 1-3 years apart. Br J Nutr 94:873-876. doi:10.1079/BJN20051565
53. Akaza H, Miyanaga N, Takashima N et al (2004) Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34:86-89. doi:10.1093/jjco/hyh015
54. Lampe JW, Skor HE, Li S et al (2001) Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr 131:740-744
55. Vedrine N, Mathey J, Morand C et al (2006) One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur J Clin Nutr 60:1039-1045. doi:10.1038/sj.ejcn.1602415
56. Nettleton JA, Greany KA, Thomas W et al (2004) Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer. J Nutr 134:1998-2003